I first wrote about substitute skin in 1993. And at the time, it seemed that stand-in organs—at scale—were imminent.
Good science does not equate to workable manufacturing. This has been a longstanding truth in tissue engineering, a field that has been in limbo between academic R&D and commercialization for its entire decades-long existence.
